Tag: weight

‘I like to carry that weight’: How Socceroos skipper-in-waiting learnt to excel under pressur…

Explore the latest developments concerning ‘I like to.

‘I like to carry that weight’: How Socceroos skipper-in-waiting learnt to excel under pressure

Santa Clara: It’s impossible to prepare for the feeling of carrying a nation’s hopes into a World Cup.

But carrying the hopes of a football-mad Italian city, where relegation threatens livelihoods, business and civic pride? Every single week?

So when Alessandro Circati says he feels no extra burden playing for the Socceroos at a World Cup, it’s not bravado. Having just played a huge role in helping Parma avoid the drop in Italy’s Serie A, responsibility has become his comfort zone.

“Staying in Serie A means so much to the city, so much to the people,” Circati says.

PL contenders, European giants circling $100m Socceroos trio as World Cup sparks transfer frenzy

There’s nothing like a World Cup to get the transfer rumours going, and many a big move has been made off the back of a good tournament showing.

With performances like the one against Türkiye, there’s a good chance some Socceroos will be the next to cash-in on the World Cup and get on the move.

Tszyu v Spence Jr. | Sunday July 26 from 11am AEST | Tim Tszyu takes on the biggest name in his career so far – future hall-of-famer Errol Spence Jr, in a can’t miss event for boxing fans around the world. | Order Now with Main Event on Kayo Sports.

Professional Diode Ice Titanium Laser Body Hair Removal Machine 3 Wavelength 755/808/1064nm Face Hair Remove for Salon Epilator

Check it out! »

Alessandro Circati chose Australia over Italy. His dad approves

Alessandro Circati (right) has captained both Australia and Parma in his relatively short career so far. (Getty Images: FIFA/Jared C. Tilton)

Alessandro Circati has worn the captain's armband for Australia, and at 22, is one of the country's best players.

Stay across the latest news, analysis and features from the 2026 FIFA World Cup here.

But his decision to play for the Socceroos raised eyebrows within his family in Italy, where he was born.

Alessandro Circati has enjoyed a successful start to his international career, becoming a vital piece of Tony Popovic's defensive unit. (Getty Images: Ercin Erturk/Anadolu)

"At the start, they didn't understand his decision to play for Australia," said his father, Gianfranco Circati.

For more detailed information, explore updates concerning ‘I like to.

For more news…

June 26, 2026
People coming off weight-loss injections risk fast weight gain | Stopping weight-loss jabs leads …

Explore the latest developments concerning People coming off.

People coming off weight-loss injections risk fast weight gain

Slimmers who come off weight-loss injections such as Mounjaro or Wegovy can regain their lost pounds four times faster than those who stop conventional dieting and exercising, new research suggests.

Data published in the British Medical Journal suggests overweight people shed large amounts when using jabs – about a fifth of their body weight – but once they quit they regain 0.8 kg every month, on average.

That means they return to their pre-treatment weight in a year and a half.

"People buying these need to be aware of the risk of fast weight regain when the treatment ends," warns investigator Dr Susan Jebb, from Oxford University.

Stopping weight-loss jabs leads to much faster rebound than thought – so are they still worth it?

Sam West receives funding from the National Institute of Health Research and is a co-investigator on three weight loss trials funded by the Novo Nordisk Foundation.

Dimitrios Koutoukidis receives funding from the National Institute of Health Research and is principal investigator in publicly-funded investigator-led research studies where Oviva and Nestle Health Sciences have contributed to the costs or delivery of weight-loss interventions. He supervised an iCASE PhD studentship where Second Nature was an industry partner.

Susan Jebb receives research grant funding from National Institute of Health Research and is principal investigator in a research programme funded by the Novo Nordisk Foundation

Oviva, Second Nature, Nestle Health Sciences have contributed to the costs or delivery of weight-loss interventions as part of some of research studies funded by the National Institute of Health Research.

ICY DBS blyth doll 1/6 bjd toy joint body white skin shiny & matte face 30cm on sale special price toy gift anime doll

Limited time offer! »

The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.

For more detailed information, explore updates concerning People coming off.

For more news…

January 11, 2026
Weight loss drug recommended for PBS | newsGP – Wegovy recommended for PBS listing | Aussies with…

Explore the latest developments concerning Weight loss drug.

newsGP – Wegovy recommended for PBS listing

The PBAC recommended it be listed for adults with established cardiovascular disease with obesity, while also identifying which groups could have more affordable access to GLP-1s.

Semaglutide (sold as Wegovy) is now a significant step closer to being added to the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease with obesity.

It comes after the Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing at its November meeting, releasing its decision late on Friday.

‘Patients must have already experienced a cardiovascular event such as a heart attack, stroke, or have symptomatic peripheral arterial disease,’ PBAC said.

‘To best reach patients at high risk and considering the high cost of treatment, the PBAC determined it would be appropriate to limit PBS access to people with a BMI of 35 kg/m² or higher, or 32.5 kg/m² or higher for people of Asian, Aboriginal, or Torres Strait Islander ethnicity.’

The cost barrier to some Australians accessing weight-loss drugs more broadly could also soon be lifted following new PBAC advice to the health minister.

At the request of Federal Health and Ageing Minister Mark Butler, the PBAC undertook a comprehensive review of glucagon-like peptide-1 (GLP-1) receptor agonist medicines for obesity, focussing on equitable access.

The PBAC has now released its recommendation on which groups should be prioritised to ensure ‘equitable subsidised access to GLP-1 for the treatment of obesity’.

‘Based on current evidence’, the PBAC considered this should include:

Pink Lace Front Wig Human Hair For Women 13×4 Hd Lace Frontal Wig Brazilian 613 13×6 Colored Straight Lace Front Wigs

Click for more info. »

The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.

For more detailed information, explore updates concerning Weight loss drug.

For more news…

December 20, 2025